A case control study to compare prevalence of liverfibrosis in patients with Acanthosis and Non Acanthosis.
Not Applicable
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/06/054229
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with T2DM (up to 15 years Duration)
2. Age 25 to 60 years
3. BMI >25 kg/m² to >40 kg/m²
4. Gender- Both (Male & Female)
5. Mild, Moderate and Severe acanthosis nigricans (Photograph)
Exclusion Criteria
1. Chronic Alcoholic with Moderate to Severe.
2. BMI >40 kg/m²
3. Congestive heart disease
4. Positive hepatitis B or hepatitis C, secondary causes of fatty liver (eg. consumption of
amiodarone and tamoxifen) and congestive hepatopathy.
5. Severe end organ damage or chronic diseases: renal/hepatic failure, any malignancy,
major systemic illness etc.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Compare prevalence of liver fibrosis in patients with acanthosis nigricans and <br/ ><br>without acanthosis nigricans subjects.Timepoint: 12 MONTHS
- Secondary Outcome Measures
Name Time Method To determine the association between acanthosis nigricans and liver fibrosis.Timepoint: 12 MONTHS